Vasoactive intestinal peptide induces Sα/Sμ switch circular DNA in human B cells

Journal of Clinical Investigation

Volumn 98, Issue 7, 1996, Pages 1527-1532

  Fujieda, Shigeharu ^a,b   Waschek, James A ^a   Zhang, Ke ^a   Saxon, Andrew ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b UNIVERSITY OF FUKUI   (Japan)

Author keywords

IgA isotype switching; switch circular DNA; transforming growth factor ; vasoactive intestinal peptide; germ line transcript

Indexed keywords

CD40 ANTIGEN; CIRCULAR DNA; IMMUNOGLOBULIN A; IMMUNOGLOBULIN D; MONOCLONAL ANTIBODY; VASOACTIVE INTESTINAL POLYPEPTIDE;

ANTIBODY PRODUCTION; ANTIBODY RESPONSE; ANTIGEN SPECIFICITY; ARTICLE; B LYMPHOCYTE; CONTROLLED STUDY; HUMAN; HUMAN CELL; IMMUNOMODULATION; PRIORITY JOURNAL;

EID: 0029820285     PISSN: 00219738     EISSN: None     Source Type: Journal    
DOI: 10.1172/JCI118944     Document Type: Article

References (61)

1. Esser, C., and A. Radbruch. 1990. Immunoglobulin class switching: molecular and cellular analysis. Annu. Rev. Immunol. 8:717-735.
2. Yuan, R., A. Casadevall, G. Spira, and M.D. Scharff. 1995. Isotype switching from IgG3 to IgG1 converts a nonprotective murine antibody to Cryptococcus neoformans into a protective antibody. J. Immunol. 154:1810-1816.
3. Honjo, T., and T. Kataoka. 1978. Organization of immunoglobulin heavy chain genes and allelic deletion model. Proc. Natl. Acad. Sci. USA. 75:2140-2144.
4. Schwedler, U.V., H.M. Jack, and M. Wabl. 1990. Circular DNA is a product of the immunoglobulin class switch rearrangement. Nature (Lond.). 345: 452-456.
5. Matsuoka, M., K. Yoshida, T. Maeda, S. Usuda, and H. Sakano. 1990. Switch circular DNA formed in cytokine-treated mouse splenocytes: evidence for intramolecular DNA deletion in immunoglobulin class switch. Cell. 62:135-142.
6. Iwasato, T., A. Shimizu, T. Honjo, and H. Yamagishi. 1990. Circular DNA is excised by immunoglobulin class switch recombination. Cell. 62:143-149.
7. Yoshida, K., M. Matsuoka, S. Usuda, A. Mori, K. Ishizaka, and H. Sakano. 1990. Immunoglobulin switch circular DNA in the mouse infected with Nippostrongylus brasiliensis: evidence for successive class switching from μ to ∈ via γ1. Proc. Natl. Acad. Sci. USA. 87:7829-7833.
8. Iwasato, T., H. Arakawa, A. Shimizu, T. Honjo, and H. Yamagishi. 1992. Biased distribution of recombination sites within S regions upon immunoglobulin class switch recombination induced by transforming growth factor β and lipopolysaccharide. J. Exp. Med. 175:1539-1546.
9. Zhang, K., F.C. Mills, and A. Saxon. 1994. Switch circles from IL-4-directed ∈ class switching from human B lymphocytes. Evidence for direct, sequential, and multiple step sequential switch from μ to ∈ Ig heavy chain gene. J. Ummunol. 152:3427-3435.
10. Fujieda, S., K. Zhang, and A. Saxon. 1995. IL-4 plus CD40 monoclonal antibody induces human B cells γ subclass specific isotype switching: switching to γ1, γ3, and γ4, but not γ2. J. Immunol. 155:2318-2328.
11. Lehman, D.A., F.D. Lee, and R.L. Coffman. 1990. Mechanism for transforming growth factor β and IL-2 enhancement of IgA expression in lipopolysaccharide-stimulated B cell cultures. J. Immunol. 144:952-957.
12. Defrance, T., B. Vanbervliet, F. Brière, I. Durand, F. Rousset, and J. Banchereau. 1992. Interleukin 10 and transforming growth factor β cooperate to induce anti-CD40-activated naive human B cells to secrete immunoglobulin A. J. Exp. Med. 175:671-682.
13. Vlasselaer, P., J. Punnonen, and J.E. Vries. 1992. Transforming growth factor-β directs IgA switching in human B cells. J. Immunol. 148:2062-2067.
14. +/A B cells to express and secrete IgA. J. Immunol. 149:1771-1778.
15. Kimata, H., and M. Fujimoto. 1994. Vasoactive intestinal peptide specifically induces human IgA1 and IgA2 production. Eur. J. Immunol. 24:2262-2265.
16. Kimata, H., and M. Fujimoto. 1995. Induction of IgA1 and IgA2 production in immature human fetal B cells and pre-B cells by vasoactive intestinal peptide. Blood. 85:2098-2104.
17. Boirivant, M., S. Fais, B. Annibale, D. Agostini, G.D. Fave, and F. Pallone. 1994. Vasoactive intestinal polypeptide modulates the in vitro immunoglobulin A production by intestinal lamina propria lymphocytes. Gastroenterology. 106:576-582.
18. Zhang, K., E.A. Clark, and A. Saxon. 1991. CD40 stimulation provides an IFN-γ-independent and IL-4-dependent differentiation signal directly to human B cells for IgE production. J. Immunol. 146:1836-1842.
19. Macy, E., D.M. Kemeny, and A. Saxon. 1988. Enhanced ELISA: how to measure less than 10 picograms of a specific protein (immunoglobulin) in less than 8 hours. FASEB (Fed. Am. Soc. Exp. Biol.) J. 2:3003-3010.
20. Griffin, B.E., E. Björck, G. Bjursell, and T. Lindahl. 1981. Sequence complexity of circular Epstein-Barr virus DNA in transformed cells. J. Virol. 40:11-19.
21. Chomczynski, P., and N. Sacchi. 1987. Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction. Anal. Biochem. 162:156-159.
22. Mills, F.C., J.S. Brooker, and R.D. Camerini-Otero. 1990. Sequences of human immunoglobulin switch regions: implications for recombination and transcription. Nucleic Acids Res. 18:7305-7316.
23. Nilsson, L., K.B. Islam, O. Olafsson, I. Zalcberg, C. Samakovlis, L. Hammarstrom, C.I.E. Smith, and P. Sideras. 1991. Structure of TGF-β1-induced human immunoglobulin Cα1 and Cα2 germ-line transcripts. Int. Immunol. 3:1107-1115.
24. Islam, K.B., B. Baskin, L. Nilsson, L. Hammarstrom, P. Sideras, and C.I.E. Smith. 1994. Molecular analysis of IgA deficiency. Evidence for impair switching to IgA. J. Immunol. 152:1442-1452.
25. Flanagan, J.G., M. Lefranc, and T.H. Rabbits. 1984. Mechanism of divergence and convergence of the human immunoglobulin α1 and α2 constant region gene sequences. Cell. 36:681-688.
26. Kitani, A., and W. Strober. 1994. Differential regulation of Cα1 and Cα2 germ-line and mature mRNA transcripts in human peripheral blood B cells. J. Immunol. 153:1466-1477.
27. Stavnezer-Nordgren, J., and S. Sirlin. 1986. Specificity of immunoglobulin heavy chain switch correlates with activity of germline heavy chain genes prior to switching. EMBO (Eur. Mol. Biol. Organ.) J. 5:95-102.
28. H replacement by a LINE-I sequence and directed class switching. EMBO (Eur. Mol. Biol. Organ.) J. 5:3259-3266.
29. Jung, S., K. Rajewsky, and A. Radbruch. 1993. Shutdown of class switch recombination by deletion of a switch region control element. Science (Wash. DC). 259:984-987.
30. Zhang, J., A. Bottaro, S. Li, V. Stewart, and F.W. Alt. 1993. A selective defect in IgG2b switching as a result of targeted mutation of the Iγ2b promoter andexon. EMBO (Eur. Mol. Biol. Organ.) J. 12:3529-3537.
31. Xu, L., B. Gorham, S.C. Li, A. Bottaro, F.W. Alt, and P. Rothman. 1993. Replacement of germ-line ∈ promoter by gene targeting alters control of immunoglobulin heavy chain class switching. Proc. Natl. Acad. Sci. USA. 90: 3705-3709.
32. Bottaro, A., R. Lansford, L. Xu, J. Zhang, P. Rothman, and F.W. Alt. 1994. S region transcription per se promotes basal IgE class switch recombination but additional factors regulate the efficiency of the process. EMBO (Eur. Mol. Biol. Organ.) J. 13:665-674.
33. Lorenz, M., S. Jung, and A. Radbruch. 1995. Switch transcripts in immunoglobulin class switching. Science (Wash. DC). 267:1825-1828.
34. Harriman, G.R., A. Bradley, S. Das, P.R. Fani, and A.C. Davis. 1996. IgA class switch in Iα exon-deficient mice. Role of germline transcription in class switch recombination. J. Clin. Invest. 97:477-485.
35. Chu, C.C., W.E. Paul, and E.E. Max. 1992. Quantitation of immunoglobulin μ-γ1 heavy chain switch region recombination by a digestion-circularization polymerase chain reaction method. Proc. Natl. Acad. Sci. USA. 89:6978-6982.
36. Borish, L., A. Aarons, J. Rumbyrt, P. Cvietusa, J. Negri, and S. Wenzel. 1996. Interleukin-10 regulation in normal subjects and patients with asthma. J. Allergy Clin. Immunol. 97:1288-1297.
37. Goetzl, E.J., D.C. Adelman, and S.P. Sreedharan. 1990. Neuroimmunology. Adv. Immunol. 48:161-190.
38. Ottaway, C.A., and A.J. Husband. 1992. Central nervous system influences on lymphocyte migration. Brain Behav. Immun. 6:97-116.
39. Kimata, H., A. Yoshida, M. Fujimoto, and H. Mikawa. 1993. Effect of vasoactive intestinal peptide, somatostatin, and substance P on spontaneous IgE and IgG4 production in atopic patients. J. Immnol. 150:4630-4640.
40. Xin, Z., H. Tang, and D. Ganea. 1994. Vasoactive intestinal peptide inhibits interleukin (IL)-2 and IL-4 production in murine thymocytes activated via the TCR/CD3 complex. J. Neuroimmunol. 54:59-68.
41. Said, S.I. 1984. Vasoactive intestinal polypeptide (VIP): current status. Peptides. 5:143-150.
42. Ueyama, T., K. Kozuki, T. Houtani, M. Ikeda, M. Kitajiri, T. Yamashita, T. Kumazawa, I. Nagatsu, and T. Sugimoto. 1990. Immunolocalizalion of tyrosine hydroxylase and vasoactive intestinal polypeptide in nerve fibers innervating human palatine tonsil and paratonsillar gland. Neurosci. Lett. 116:70-74.
43. Baraniuk, J.N., J.D. Lundgren, M. Okayama, J. Mullol, M. Merida, J.H. Shelhamer, and M.A. Kaliner. 1990. Vasoactive intestinal peptide in human nasal mucosa. J. Clin. Invest. 86:825-831.
44. Ottaway, C.A. 1991. Neuroimmunomodulation in the intestinal mucosa. Gastroenterol. Clin. North Am. 20:511-529.
45. Danek, A., M.S. O'Dorisio T.M. O'Dorisio, and J.M. George. 1983. Specific binding sites for vasoactive intestinal polypeptide on nonadherent peripheral blood lymphocytes. J. Immunol. 131:1173-1177.
46. Ottaway, C.A., T.E. Lay, and G.R. Greenberg. 1990. High affinity specific binding of vasoactive intestinal peptide to human circulating T cells, B cells and large granular lymphocytes. J. Neuroimmunol. 29:149-155.
47. Ottaway, C.A. 1987. Selective effects of vasoactive intestinal peptide on the mitogenic response of murine T cells. Immunology. 62:291-297.
48. Johnston, J.A., D.D. Taub, A.R. Lloyd, K. Conlon, J.J. Oppenheim, and D.J. Kevlin. 1994. Human T lymphocyte chemotaxis and adhesion induced by vasoactive intestinal peptide. J. Immunol. 153:1762-1768.
49. Waschek, J.A., D.T. Bravo, and M.L. Richards. 1995. High levels of VIP/PACAP receptor gene expression in primary and tumor lymphoid cells. Regul. Pept. 60:149-157.
50. Chaen, T., N. Watanabe, G. Mogi, K. Mori, and M. Takeyama. 1993. Substance P and vasoactive intestinal peptide in nasal secretins and plasma from patients with nasal allergy. Ann. Otol. Rhinol. Laryngol. 102:16-21.
51. Mosimann, B.L., M.V. White, R.J. Hohman, M.S. Goldrich, H.C. Kaulbach, and M.A. Kaliner. 1993. Substance P. calcitonin gene-related peptide, and vasoactive intestinal peptide increase in nasal secretions after allergen challenge in atopic patients. J. Allergy Clin. Immunol. 92:95-104.
52. Goetzl, E.J., S.P. Sreedharan, and H.B. Kaltreider. 1994. Neuroregulation of pulmonary immunity: the roles of substance P and vasoactive intestinal peptide. In Neuropeptides in Respiratory Medicine. M.A. Kaliner, P.J. Barnes, G.H.H. Kunkel, and J.N. Baraniuk, editors. Marcel Dekker, New York. 607-620.
53. Schulzke, J.D., E.D. Riecken, and M. Fromm. 1995. Distension-induced electrogenic Cl secretion is mediated via VIP-ergic neurons in rat rectal colon. Am. J. Physiol. 268:G725-G731.
54. Kilian, M., J. Mestecky, and M.W. Russell. 1988. Defense mechanisms involving Fc-dependent functions of immunoglobulin A and their subversion by bacterial immunoglobulin A proteases. Microbiol. Rev. 52:296-303.
55. Mazanec, M.B., J.G. Nedrud, C.S. Kaetzel, and M.E. Lamm. 1993. A three-tiered view of the role of IgA in mucosal defense. Immunol. Today. 14: 430-434.
56. Ottaway, C.A. 1984. In vitro alteration of receptors for vasoactive intestinal peptide changes the in vivo localization of mouse T cells. J. Exp. Med. 160: 1054-1069.
57. Bondesson, L., K. Norolind, S. Liden, G. Gafvelin, E. Theodorsson, and V. Mutt. 1991. Dual effects of vasoactive intestinal peptide (VIP) on leucocyte migration. Acta Physiol. Scand. 141:477-481.
58. Pleszczynski, M.R., D. Bolduc, and S.S. Pierre. 1985. The effect of vasoactive intestinal peptide on human natural killer cell function. J. Immunol. 135: 2569-2573.
59. Chedeville, A., L. Mirossay, E. Chastre, I. Hurbain-Kosmath, M. Lopez, and C. Gespach. 1993. Interaction of VIP, PACAP and related peptides in normal and leukemic human monocytes and macrophages. FEBS Lett. 319:171-176.
60. Berisha, H., H. Foda, H. Sakakibara, M. Trotz, H. Pakbaz, and S.I. Said. 1990. Vasoactive intestinal peptide prevents lung injury due to xanthine/xanthine oxidase. Am. J. Physiol. 259:L151-L155.
61. Said, S.I. 1991. VIP as a modulator of lung inflammation and airway constriction. Am. Rev. Respir. Dis. 143:S22-S24.